|
2025
|
G/S
|
Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthal... |
|
|
Invention
|
Methods and compositions for the prevention and treatment of duchenne muscular dystrophy.
The di... |
|
|
Invention
|
Methods, compositions, and uses related to the treatment and prevention of leigh syndrome.
The p... |
|
2024
|
Invention
|
Methods and compositions for the treatment of age-related macular degeneration.
The present tech... |
|
|
Invention
|
Methods, compositions and uses related to the treatment and prevention of leigh’s syndrome.
The ... |
|
|
G/S
|
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular,... |
|
|
Invention
|
Cyclo-hexa-2,5-diene-1,4-diones for use in the treatment of cardiomyopathy. The present disclosur... |
|
|
Invention
|
Combination therapy for the treatment of friedreich's ataxia.
The present disclosure provides a ... |
|
|
Invention
|
Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2.
Disclosed are various crystalline sal... |
|
|
Invention
|
Methods for the treatment of mitochondrial disease.
The disclosure provides methods of preventin... |
|
|
Invention
|
Methods for addressing injection site reactions associated with the administration of bevemipreti... |
|
|
G/S
|
biological preparations for the prevention and treatment of cellular abnormalities.; Biopharmaceu... |
|
|
Invention
|
Methods, compositions and uses related to the treatment and prevention of leigh's syndrome. The p... |
|
|
Invention
|
Small molecule peptidomimetic for the treatment of tauopathies.
The present disclosure provides ... |
|
|
Invention
|
Combination therapy for the treatment of friedreich's ataxia. The present disclosure provides a c... |
|
|
Invention
|
Methods and compositions for the treatment or prevention of muscular dystrophy.
The disclosure p... |
|
|
Invention
|
Methods and compositions for the treatment of age-related macular degeneration. The present techn... |
|
|
Invention
|
Compositions and methods for the treatment of amyotrophic lateral sclerosis, parkinson’s disease,... |
|
|
Invention
|
Compositions and methods for the prevention and/or treatment of mitochondrial disease, including ... |
|
|
Invention
|
Addressing injection site reactions associated with the administration of elamipretide.
The pres... |
|
|
Invention
|
Crystalline dipeptides useful in the synthesis of elamipretide.
Disclosed are crystalline forms ... |
|
|
Invention
|
Methods and compositions for preventing or treating dominant optic atrophy.
The disclosure gener... |
|
|
Invention
|
Aromatic-cationic peptides and uses of same.
The disclosure provides compositions and methods re... |
|
2023
|
Invention
|
Methods and compositions for the treatment of neurodegenerative disease. The present disclosure p... |
|
|
G/S
|
Medical billing support services Providing health information on mitochondrial disease, its treat... |
|
|
Invention
|
Methods and compositions for treating, preventing, inhibiting, ameliorating or delaying the onset... |
|
|
Invention
|
Methods and compositions for the prevention or treatment of barth syndrome. The disclosure provid... |
|
|
Invention
|
Methods and compositions for preventing or treating ophthalmic conditions. The disclosure general... |
|
|
Invention
|
2. 2. |
|
|
Invention
|
Mitochondria-targeting peptides.
Disclosed are non-natural peptides useful for the treatment and... |
|
|
Invention
|
Addressing injection site reactions associated with the administration of elamipretide |
|
|
Invention
|
Addressing injection site reactions associated with the administration of elamipretide. The prese... |
|
|
Invention
|
Compositions and methods for the treatment of huntington's disease and htt proteinopathies |
|
|
Invention
|
Compositions and methods for the treatment of huntington's disease and htt proteinopathies. The p... |
|
|
Invention
|
Methods and compositions for the prevention and treatment of friedreich's ataxia.
The disclosure... |
|
|
Invention
|
Compositions and methods for the prevention and treatment of mitochondrial myopathies.
The discl... |
|
|
Invention
|
Therapeutic compositions including spn10 and uses thereof.
Disclosed herein are methods and comp... |
|
|
Invention
|
Deuterated tetrapeptides that target mitochondria.
Disclosed are deuterated analogs of SBT-20 an... |
|
|
Invention
|
Methods and compositions for preventing or treating ophthalmic conditions.
The disclosure genera... |
|
|
Invention
|
Methods and compositions for preventing or treating leber's hereditary optic neuropathy.
The dis... |
|
|
Invention
|
Small molecule peptidomimetic for the treatment of tauopathies |
|
|
Invention
|
Small molecule peptidomimetic for the treatment of tauopathies. The present disclosure provides n... |
|
2022
|
Invention
|
Crystalline dipeptides useful in the synthesis of elamipretide. 2 and Boc-D-Arg-DMT. The crystall... |
|
|
Invention
|
Crystalline salt forms. 2. |
|
|
Invention
|
Compounds, compositions and methods for the prevention and/or treatment of various mitochondrial ... |
|
|
Invention
|
Silica-based formulations of therapeutic oliogpeptides and peptidomimetics.
Disclosed are depot ... |
|
2021
|
G/S
|
Biopharmaceutical preparations for the prevention and treatment of cardiovascular, renal, ophthal... |
|
|
Invention
|
Prodrugs of mitochondria-targeting oligopeptides.
Disclosed are various prodrugs of L-Phe-D-Arg-... |
|
|
Invention
|
Prodrugs of mitochondria-targeting oligopeptides.
Disclosed are various prodrugs of Elamipretide. |
|
|
Invention
|
Methods and compositions for the treatment of muscular dystrophy.
The disclosure provides method... |
